Overview
Find compounds researched for skin quality, visible recovery, pigmentation, collagen support, and cosmetic-adjacent outcomes.
5 of 46 published compounds
$80.00
Skin & Hair
skin quality, hair support, appearance, collagen signaling
Goal hub next step
Build a skin, hair & appearance research path.
Use the quiz before choosing a compound, vendor, or PDF so the route reflects your goal, risk tolerance, and monitoring comfort.
Best options to research first
Ranked by evidence first, then risk. A research starting point, not a clinical recommendation.
Melanotan I
FDA-approved MC1R agonist (SCENESSE implant) for erythropoietic protoporphyria. Prescription only.
subcutaneous implant
Controlled-release kinetics; plasma concentrations up to ~96 hours in most subjects.
2 tracked
GHK-Cu
Copper peptide complex with substantial topical/cosmetic literature for skin and hair repair.
topical
Skin remodeling: weeks to months (collagen turnover cycles).
$60.00
3 tracked
LL-37
Human antimicrobial peptide with topical wound healing studies. Antimicrobial therapeutic claims trigger regulatory scrutiny.
topical
Wound endpoints measured over weeks.
0 tracked
KPV
Anti-inflammatory α-MSH tripeptide fragment studied in cell and animal models for NF-κB inhibition.
topical, subcutaneous
Cell signaling endpoints are acute; clinical translation unknown.
$31.99
3 tracked
Lower-risk options
Higher-risk options
Topical appears tolerable; systemic use carries different risk profile.
FDA cites serious adverse events: melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome, priapism. Immunogenicity/impurity concerns.
Trusted vendors for skin and cosmetic research
These vendors currently carry compounds in this goal category. Hub is the trust layer; outbound clicks happen after comparison.
Amino Club
4 relevant compounds in hub
product page COA viewer
third-party purity testing; product-level COA on page
US/ROW (verify current policy)
affiliate: public program
XL Peptides
4 relevant compounds in hub
testing reports on product page
third-party testing reports linked on product page
UK, Europe, and rest of world via vendor shipping options
affiliate: direct product page
Ignite Peptides
3 relevant compounds in hub
COA with order / verify current product report
third-party testing and COA documentation claimed by vendor; verify product-specific report
U.S. domestic territories only
affiliate: direct product page
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.